SCHEMBL2144990

SCHEMBL2144990

CN1CCc2ccc(Nc3nc4cccc(NC5CCOCC5)n4n3)cc21

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 14/20 0.39
JAK3 P52333 12/20 0.39
PTK2 Q05397 12/20 0.39
IDH2 P48735 1/20 0.37
BRD4 O60885 2/20 0.37
AXL P30530 2/20 0.36
ETV6 P41212 2/20 0.36
CSNK2A1 P68400 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2145354 0.89 JAK2 (0.40) JAK2JAK3PTK2IDH2CSNK2A1
SCHEMBL3309853 0.84 JAK2 (0.38) JAK2JAK3PTK2
SCHEMBL2144632 0.80 JAK2 (0.37) JAK2JAK3PTK2
SCHEMBL2144764 0.80 KIT (0.46) JAK2JAK3PTK2
SCHEMBL3307376 0.80 JAK2 (0.43) JAK2JAK3PTK2
SCHEMBL13392671 0.79 CDK2 (0.46) JAK2JAK3PTK2BRD4CSNK2A1
SCHEMBL13391687 0.79 EML4 (0.40) JAK2JAK3PTK2BRD4CSNK2A1
SCHEMBL3309578 0.76 JAK2 (0.36) JAK2JAK3PTK2
SCHEMBL13392641 0.76 JAK2 (0.39) JAK2JAK3PTK2BRD4
SCHEMBL2144106 0.76 JAK2 (0.42) JAK2JAK3PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2344494-A1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS Signal Pharmaceuticals, LLC (US) 2011-07-20 EP claimed
WO-2010027500-A1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2010-03-11 WO claimed
EP-2344494-A1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS Signal Pharmaceuticals, LLC (US) 2011-07-20 EP disclosed
WO-2010027500-A1 AMINOTRIAZOLOPYRIDINES AND THEIR USE AS KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2010-03-11 WO disclosed